-- Zhejiang CONBA Pharmaceutical (SHA:600572) unit Hangzhou Konzern obtained a registration certificate for telmisartan and amlodipine tablets from China's drug regulator.
The tablets are a combination drug for essential hypertension, according to a Friday filing with the Shanghai bourse.